BeyondSpring (NASDAQ:BYSI) Stock Price Down 6.6%

BeyondSpring Inc. (NASDAQ:BYSI)’s share price was down 6.6% during mid-day trading on Thursday . The stock traded as low as $2.26 and last traded at $2.27. Approximately 28,389 shares were traded during mid-day trading, a decline of 85% from the average daily volume of 185,227 shares. The stock had previously closed at $2.43.

BeyondSpring Stock Performance

The firm’s 50 day moving average price is $2.42 and its 200 day moving average price is $1.47.

Hedge Funds Weigh In On BeyondSpring

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Decheng Capital Management III Cayman LLC bought a new position in shares of BeyondSpring during the third quarter valued at approximately $3,967,000. Capstone Capital Wealth Advisors bought a new position in BeyondSpring in the 4th quarter worth about $45,000. Finally, Decheng Capital LLC purchased a new position in shares of BeyondSpring during the fourth quarter worth approximately $4,450,000. Hedge funds and other institutional investors own 40.29% of the company’s stock.

About BeyondSpring

BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer.